Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Antoch

Showing results (421-430 of 443) with videos related to

Pageof 45
Sort By:
BMC Oral Health|March 21, 2026
Radiation-induced oral side effects in head and neck cancer: a scoping review and interdisciplinary recommendationsTill Gerlach, Giulia Brunello, Carina Tenbrink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2022
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on <sup>18</sup>F-FDG PET/MRI and Machine LearningJanna Morawitz, Benjamin Sigl, Christian Rubbert, et al.
Journal of Behavioral Medicine|March 5, 2025
Worry about prostate cancer and risk perception among middle-aged men: results from the PROBASE trialValentin H Meissner, Andreas Dinkel, Martina Kron, et al.
European Urology Oncology|July 10, 2025
Do We Need Early Detection of Grade Group 2 Prostate Cancer in a Screening Program for Young Men? Results from the PROBASE Screening TrialPeter Albers, Agne Krilaviciute, Petra Seibold, et al.
European Journal of Medical Research|February 9, 2023
Percutaneous fractionated radiotherapy of the groin to eliminate lymphatic fistulas after vascular surgeryDanny Jazmati, Bálint Tamaskovics, Norman-Philipp Hoff, et al.
European Urology|May 15, 2024
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE TrialAgne Krilaviciute, Rudolf Kaaks, Petra Seibold, et al.
European Urology Oncology|October 8, 2023
Digital Rectal Examination Is Not a Useful Screening Test for Prostate CancerAgne Krilaviciute, Nikolaus Becker, Jale Lakes, et al.
Frontiers in Immunology|May 20, 2021
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft FailureVerena Keitel, Johannes Georg Bode, Torsten Feldt, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 29, 2022
Vision, Development, and Structure of the First German Specialist Training Curriculum for RadiologyIsabel Molwitz, Anne Frisch, Gerhard Adam, et al.
European Urology|June 3, 2025
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE TrialRouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
Pageof 45

Showing results (421-430 of 443) with videos related to

Sort By:
Pageof 45
BMC Oral Health|March 21, 2026
Radiation-induced oral side effects in head and neck cancer: a scoping review and interdisciplinary recommendationsTill Gerlach, Giulia Brunello, Carina Tenbrink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2022
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on <sup>18</sup>F-FDG PET/MRI and Machine LearningJanna Morawitz, Benjamin Sigl, Christian Rubbert, et al.
Journal of Behavioral Medicine|March 5, 2025
Worry about prostate cancer and risk perception among middle-aged men: results from the PROBASE trialValentin H Meissner, Andreas Dinkel, Martina Kron, et al.
European Urology Oncology|July 10, 2025
Do We Need Early Detection of Grade Group 2 Prostate Cancer in a Screening Program for Young Men? Results from the PROBASE Screening TrialPeter Albers, Agne Krilaviciute, Petra Seibold, et al.
European Journal of Medical Research|February 9, 2023
Percutaneous fractionated radiotherapy of the groin to eliminate lymphatic fistulas after vascular surgeryDanny Jazmati, Bálint Tamaskovics, Norman-Philipp Hoff, et al.
European Urology|May 15, 2024
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE TrialAgne Krilaviciute, Rudolf Kaaks, Petra Seibold, et al.
European Urology Oncology|October 8, 2023
Digital Rectal Examination Is Not a Useful Screening Test for Prostate CancerAgne Krilaviciute, Nikolaus Becker, Jale Lakes, et al.
Frontiers in Immunology|May 20, 2021
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft FailureVerena Keitel, Johannes Georg Bode, Torsten Feldt, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 29, 2022
Vision, Development, and Structure of the First German Specialist Training Curriculum for RadiologyIsabel Molwitz, Anne Frisch, Gerhard Adam, et al.
European Urology|June 3, 2025
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE TrialRouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
Pageof 45